BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma

Research output: Contribution to journalReview article

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1351-1353
Number of pages3
JournalImmunotherapy
Volume8
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Immunotherapy
Melanoma
Cell Death
Biomarkers
T-Lymphocytes
Therapeutics

Keywords

  • Bim
  • immunotherapy
  • melanoma
  • PD-1
  • PD-L1
  • T cell

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this

@article{978617cc730b458b827a54a4f7bd4860,
title = "BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma",
keywords = "Bim, immunotherapy, melanoma, PD-1, PD-L1, T cell",
author = "Dronca, {Roxana S} and Aaron Mansfield and Park, {Sean S} and Dong, {Haidong M}",
year = "2016",
month = "12",
day = "1",
doi = "10.2217/imt-2016-0100",
language = "English (US)",
volume = "8",
pages = "1351--1353",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma

AU - Dronca, Roxana S

AU - Mansfield, Aaron

AU - Park, Sean S

AU - Dong, Haidong M

PY - 2016/12/1

Y1 - 2016/12/1

KW - Bim

KW - immunotherapy

KW - melanoma

KW - PD-1

KW - PD-L1

KW - T cell

UR - http://www.scopus.com/inward/record.url?scp=85007236042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007236042&partnerID=8YFLogxK

U2 - 10.2217/imt-2016-0100

DO - 10.2217/imt-2016-0100

M3 - Review article

C2 - 27784186

AN - SCOPUS:85007236042

VL - 8

SP - 1351

EP - 1353

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 12

ER -